XELOX
XELOX is a chemotherapy regimen for treatment of colorectal cancer. It consists of Capecitabine (Xeloda) and Oxaliplatin (Eloxatin). The regimen is considered a first-line treatment for metastatic colorectal cancer.
Treatment Regimen[edit | edit source]
The XELOX regimen is typically administered in cycles. A cycle usually lasts for three weeks. During the first day of each cycle, Oxaliplatin is given intravenously over a period of two hours. Capecitabine is taken orally twice daily for the first two weeks, followed by a week of rest.
Efficacy[edit | edit source]
Several studies have shown that XELOX is as effective as the FOLFOX regimen, another first-line treatment for metastatic colorectal cancer. The choice between XELOX and FOLFOX often depends on patient preference, side effect profile, and convenience.
Side Effects[edit | edit source]
Common side effects of the XELOX regimen include nausea, vomiting, diarrhea, fatigue, and neuropathy. Severe side effects can include neutropenia, a low white blood cell count that can increase the risk of infection.
See Also[edit | edit source]
XELOX Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD